{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:02:52Z","timestamp":1790229772118,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Neuromyelitis optica spectrum disorder (NMOSD) predominantly affects women and has a median age at onset of 40 years, meaning that many patients are of childbearing age. However, management of pregnant women with NMOSD remains extremely challenging. We report two patients with NMOSD who had unplanned pregnancies during inebilizumab (INE) treatment and successful deliveries. These cases provide preliminary clinical information regarding maternal disease control and pregnancy outcomes following INE exposure.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1953059","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:44:18Z","timestamp":1790228658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Unplanned pregnancy during treatment with inebilizumab in patients with AQP4-IgG-seropositive NMOSD: report of two cases"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenqin","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.873576","article-title":"Neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody: Outcome prediction models","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200188","article-title":"Serum biomarker profiles discriminate AQP4 seropositive and double seronegative neuromyelitis optica spectrum disorder","volume":"11","author":"Carta","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16178","article-title":"Patterns of neuromyelitis optica spectrum disorder attacks in different age groups and sexes depending on the status of immunosuppressive therapy: A retrospective cohort study","volume":"31","author":"Luo","year":"2024","journal-title":"Eur J Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.21203\/rs.3.rs-7313873\/v1","article-title":"Unexpected pregnancy in a patient with AQP4-IgG\u2009+\u2009NMOSD after treatment with inebilizumab: a case report","volume":"26","author":"Wan","year":"2026","journal-title":"BMC Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jnnp-2020-323982","article-title":"Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors","volume":"92","author":"Wang","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25438","article-title":"Analysis of pregnancy-related attacks in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515583376","article-title":"Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder","volume":"22","author":"Shimizu","year":"2016","journal-title":"Mult Scler"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517740215","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management","volume":"23","author":"Shosha","year":"2017","journal-title":"Mult Scler"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1063\/9780735420991_006","article-title":"In utero exposure to maternal anti-aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring","volume":"14","author":"Mader","year":"2022","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000188","article-title":"Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder","volume":"3","author":"Nosadini","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40263-025-01191-7","article-title":"Long-term effectiveness and safety of rituximab in neuromyelitis optica spectrum disorder: A 5-year observational study","volume":"39","author":"Novi","year":"2025","journal-title":"CNS Drugs"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1513303","article-title":"The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment","volume":"15","author":"Dong","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104524","article-title":"B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab regimen for NMOSD: A real-world case series study","volume":"70","author":"Cao","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102175","article-title":"Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules","volume":"43","author":"Trewin","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103499","article-title":"Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review","volume":"23","author":"Siriratnam","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/13524585221130934","article-title":"Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society","volume":"29","author":"Vukusic","year":"2023","journal-title":"Mult Scler"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0313-y","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations","volume":"16","author":"Mao-Draayer","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"Wilcox","year":"2017","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(25)00479-x","article-title":"Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD","volume":"25","author":"Rotstein","year":"2026","journal-title":"Lancet Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a135906","article-title":"Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy","volume":"10","author":"Jauniaux","year":"1995","journal-title":"Hum Reprod"},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40263-025-01260-x","article-title":"Consensus recommendations for the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD): The MENACTRIMS guidelines","volume":"40","author":"Yamout","year":"2026","journal-title":"CNS Drugs"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01224-9","article-title":"Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management","volume":"19","author":"Krajnc","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211039648","article-title":"Multiple sclerosis therapy consensus group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)","volume":"14","author":"Wiendl","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/20552173241271878","article-title":"Pregnancy characteristics in Egyptian female patients with NMOSD","volume":"10","author":"Gad","year":"2024","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000004681","article-title":"High risk of postpartum relapses in neuromyelitis optica spectrum disorder","volume":"89","author":"Klawiter","year":"2017","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04029","article-title":"Hospital variations in caesarean delivery rates: An analysis of national data in China, 2016-2020","volume":"13","author":"Yin","year":"2023","journal-title":"J Glob Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1700807","article-title":"The mediating role of fear of childbirth in the relationship between intolerance of uncertainty and cesarean section preference among pregnant women","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/02646838.2024.2435941","article-title":"Fear of childbirth among Chinese women in the third trimester and mode of delivery","volume":"44","author":"Chen","year":"2026","journal-title":"J Reprod Infant Psychol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-018-0143-9","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies","volume":"9","author":"Borisow","year":"2018","journal-title":"Epma J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200264","article-title":"Neonatal B-cell levels and infant health in newborns potentially exposed to anti-CD20 monoclonal antibodies during pregnancy or lactation","volume":"11","author":"Schwake","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000769","article-title":"Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases","volume":"7","author":"LaHue","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp-2022-329545","article-title":"Safety of breast feeding during rituximab treatment in multiple sclerosis","volume":"94","author":"R\u00f8d","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1953059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:44:19Z","timestamp":1790228659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1953059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2026.1953059"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1953059","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1953059"}}